Home LiteratureArticle Details
PMID: 19415765 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Identification of gastric cancer stem cells using the cell surface marker CD44.

Stem cells (Dayton, Ohio) ·Vol. 27 ·No. 5 ·2009-05-00 ·Pages 1006-20

Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC

Abstract

Cancer stem cells (CSCs) have been defined as a unique subpopulation in tumors that possess the ability to initiate tumor growth and sustain tumor self-renewal. Although the evidence has been provided to support the existence of CSCs in various solid tumors, the identity of gastric CSCs has not been reported. In this study, we have identified gastric cancer-initiating cells from a panel of human gastric cancer cell lines using cell surface marker CD44. Among six gastric cancer cell lines, three lines MKN-45, MKN-74, and NCI-N87 had a sizeable subpopulation of CD44(+) cells, and these cells showed spheroid colony formation in serum-free media in vitro as well as tumorigenic ability when injected into stomach and skin of severe combined immunodeficient (SCID) mice in vivo. The CD44(+) gastric cancer cells showed the stem cell properties of self-renewal and the ability to form differentiated progeny and gave rise to CD44(-) cells. CD44 knockdown by short hairpin RNA resulted in much reduced spheroid colony formation and smaller tumor production in SCID mice, and the CD44(-) populations had significantly reduced tumorigenic ability in vitro and in vivo. Other potential CSC markers, such as CD24, CD133, CD166, stage-specific embryonic antigen-1 (SSEA-1), and SSEA-4, or sorting for side population did not show any correlation with tumorigenicity in vitro or in vivo. The CD44(+) gastric cancer cells showed increased resistance for chemotherapy- or radiation-induced cell death. These results support the existence of gastric CSCs and may provide novel approaches to the diagnosis and treatment of gastric cancer.

MeSH Terms
Animals Biomarkers, Tumor/metabolism Cell Line, Tumor Culture Media, Serum-Free Disease Models, Animal Drug Resistance, Neoplasm Humans Hyaluronan Receptors/metabolism Mice Mice, SCID Neoplastic Stem Cells/metabolism,pathology RNA, Small Interfering/metabolism Radiation Tolerance Spheroids, Cellular/pathology Stomach Neoplasms/metabolism,pathology
Chemicals
Biomarkers, Tumor Culture Media, Serum-Free Hyaluronan Receptors RNA, Small Interfering
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Takaishi Shigeo
Division of Digestive and Liver Disease, Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.
Okumura Tomoyuki
Tu Shuiping
Wang Sophie S W
Shibata Wataru
Vigneshwaran Ramanathan
Gordon Shanisha A K
Shimada Yutaka
Wang Timothy C
References (58)
58 references, click to expand
  1. Targeting of CD44 eradicates human acute myeloid leukemic stem cells.
    Nat Med. 2006 Oct;12(10):1167-74 PMID: 16998484
  2. Isolation and characterization of a putative intestinal stem cell fraction from mouse jejunum.
    Gastroenterology. 2005 Nov;129(5):1567-80 PMID: 16285956
  3. A distinct "side population" of cells with high drug efflux capacity in human tumor cells.
    Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14228-33 PMID: 15381773
  4. Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells.
    Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18700-5 PMID: 18003928
  5. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness.
    Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11154-9 PMID: 16849428
  6. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Cancer Res. 2008 May 15;68(10):3655-61 PMID: 18483247
  7. Gastric cancer originating from bone marrow-derived cells.
    Science. 2004 Nov 26;306(5701):1568-71 PMID: 15567866
  8. The epithelial-mesenchymal transition generates cells with properties of stem cells.
    Cell. 2008 May 16;133(4):704-15 PMID: 18485877
  9. Efficient tumour formation by single human melanoma cells.
    Nature. 2008 Dec 4;456(7222):593-8 PMID: 19052619
  10. Phenotypic characterization of human colorectal cancer stem cells.
    Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63 PMID: 17548814
  11. Side populations of gastrointestinal cancers are not enriched in stem cells.
    J Pathol. 2008 Apr;214(5):564-73 PMID: 18266310
  12. Presence of histamine H2-receptors on human gastric carcinoma cell line MKN-45 and their increase by retinoic acid treatment.
    Biochem Biophys Res Commun. 1991 May 15;176(3):1027-32 PMID: 1674864
  13. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells.
    Nat Med. 2006 Oct;12(10):1175-80 PMID: 16998483
  14. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.
    Am J Pathol. 1999 Feb;154(2):515-23 PMID: 10027409
  15. Prospective identification of tumorigenic breast cancer cells.
    Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8 PMID: 12629218
  16. Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1.
    Am J Pathol. 2003 Jul;163(1):3-9 PMID: 12819005
  17. Identification of a cancer stem cell in human brain tumors.
    Cancer Res. 2003 Sep 15;63(18):5821-8 PMID: 14522905
  18. Identification and expansion of human colon-cancer-initiating cells.
    Nature. 2007 Jan 4;445(7123):111-5 PMID: 17122771
  19. Modelling breast cancer: one size does not fit all.
    Nat Rev Cancer. 2007 Sep;7(9):659-72 PMID: 17721431
  20. Inflammation, atrophy, and gastric cancer.
    J Clin Invest. 2007 Jan;117(1):60-9 PMID: 17200707
  21. Identification and characterization of tumorigenic liver cancer stem/progenitor cells.
    Gastroenterology. 2007 Jun;132(7):2542-56 PMID: 17570225
  22. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer.
    Gastroenterology. 2000 Jan;118(1):36-47 PMID: 10611152
  23. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.
    Nat Med. 1997 Jul;3(7):730-7 PMID: 9212098
  24. Tumor growth need not be driven by rare cancer stem cells.
    Science. 2007 Jul 20;317(5836):337 PMID: 17641192
  25. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
    Cancer Res. 2005 Jul 15;65(14):6207-19 PMID: 16024622
  26. Functional and molecular characterisation of mammary side population cells.
    Breast Cancer Res. 2003;5(1):R1-8 PMID: 12559051
  27. Gastric cancer stem cells.
    J Clin Oncol. 2008 Jun 10;26(17):2876-82 PMID: 18539967
  28. Prospective identification of a multilineage progenitor in murine stomach epithelium.
    Gastroenterology. 2007 Dec;133(6):1989-98 PMID: 18054570
  29. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.
    Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):973-8 PMID: 17210912
  30. A crucial role for CD44 in inflammation.
    Trends Mol Med. 2001 May;7(5):213-21 PMID: 11325633
  31. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
    J Exp Med. 1996 Apr 1;183(4):1797-806 PMID: 8666936
  32. SP analysis may be used to identify cancer stem cell populations.
    Exp Cell Res. 2006 Nov 15;312(19):3701-10 PMID: 17046749
  33. Bmi1 is expressed in vivo in intestinal stem cells.
    Nat Genet. 2008 Jul;40(7):915-20 PMID: 18536716
  34. Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice.
    Stem Cells. 2008 Mar;26(3):630-7 PMID: 18055444
  35. Identification of cells initiating human melanomas.
    Nature. 2008 Jan 17;451(7176):345-9 PMID: 18202660
  36. Prospective identification of tumorigenic prostate cancer stem cells.
    Cancer Res. 2005 Dec 1;65(23):10946-51 PMID: 16322242
  37. CD44 is of functional importance for colorectal cancer stem cells.
    Clin Cancer Res. 2008 Nov 1;14(21):6751-60 PMID: 18980968
  38. Identification and expansion of the tumorigenic lung cancer stem cell population.
    Cell Death Differ. 2008 Mar;15(3):504-14 PMID: 18049477
  39. A tumorigenic subpopulation with stem cell properties in melanomas.
    Cancer Res. 2005 Oct 15;65(20):9328-37 PMID: 16230395
  40. Molecular biology. Cancer's perpetual source?
    Science. 2007 Aug 24;317(5841):1029-31 PMID: 17717165
  41. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers.
    Gastroenterology. 2005 May;128(6):1567-78 PMID: 15887152
  42. Myogenic specification of side population cells in skeletal muscle.
    J Cell Biol. 2002 Oct 14;159(1):123-34 PMID: 12379804
  43. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.
    Cell Stem Cell. 2007 Sep 13;1(3):313-23 PMID: 18371365
  44. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.
    Hepatology. 2006 Jul;44(1):240-51 PMID: 16799977
  45. CD44: from adhesion molecules to signalling regulators.
    Nat Rev Mol Cell Biol. 2003 Jan;4(1):33-45 PMID: 12511867
  46. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.
    Nature. 1994 Feb 17;367(6464):645-8 PMID: 7509044
  47. Cancer statistics, 2008.
    CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 PMID: 18287387
  48. Identification of stem cells in small intestine and colon by marker gene Lgr5.
    Nature. 2007 Oct 25;449(7165):1003-7 PMID: 17934449
  49. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.
    Cancer Res. 2006 Oct 1;66(19):9339-44 PMID: 16990346
  50. Cancer stem cells--old concepts, new insights.
    Cell Death Differ. 2008 Jun;15(6):947-58 PMID: 18259194
  51. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.
    Nature. 2007 Jan 4;445(7123):106-10 PMID: 17122772
  52. Stem cells and cancer.
    Semin Cancer Biol. 2007 Jun;17(3):191-203 PMID: 16762563
  53. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.
    J Clin Invest. 2008 Jun;118(6):2111-20 PMID: 18497886
  54. Conditional gene expression and knockdown using lentivirus vectors encoding shRNA.
    Methods Mol Biol. 2008;434:291-309 PMID: 18470652
  55. Identification of pancreatic cancer stem cells.
    Cancer Res. 2007 Feb 1;67(3):1030-7 PMID: 17283135
  56. The biology of cancer stem cells.
    Annu Rev Cell Dev Biol. 2007;23:675-99 PMID: 17645413
  57. Staining embryonic stem cells using monoclonal antibodies to stage-specific embryonic antigens.
    Methods Mol Biol. 2006;325:207-24 PMID: 16761728
  58. Significance of CD90+ cancer stem cells in human liver cancer.
    Cancer Cell. 2008 Feb;13(2):153-66 PMID: 18242515
Article Info
Journal
Stem cells (Dayton, Ohio)
Abbr.
Stem Cells
ISSN
1549-4918
Published
2009-05-00
Pages
1006-20
Language
English
Region
United States
NLM ID
9304532
PMCID
PMC2746367
Subset
IM
Grants
NCI NIH HHS · R01 CA093405 · United States
NCI NIH HHS · R01 CA120979 · United States
NCI NIH HHS · R01 CA120979-02 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]